TYROBP/DAP12 Protein

Migration, Crosslink

📖

TYROBP/DAP12 Protein

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-tyrobp-protein

📖 Wiki Page

protein918 wordssynced 2026-04-02

TYROBP/DAP12 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TYROBP/DAP12 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>TYROBP (DAP12)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>TYROBP</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y258</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~12 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cell membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>ITAM-containing adaptors</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Type</td>
</tr>
<tr>
<td class="label">sTREM2</td>
<td>Soluble protein</td>
</tr>
<tr>
<td class="label">DAP12 expression</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">p-SYK</td>
<td>Phosphoprotein</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">TREM2 Agonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TREM2 Antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Small Molecule SYK Activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color

...

TYROBP/DAP12 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TYROBP/DAP12 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>TYROBP (DAP12)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>TYROBP</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y258</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~12 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cell membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>ITAM-containing adaptors</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Type</td>
</tr>
<tr>
<td class="label">sTREM2</td>
<td>Soluble protein</td>
</tr>
<tr>
<td class="label">DAP12 expression</td>
<td>Gene expression</td>
</tr>
<tr>
<td class="label">p-SYK</td>
<td>Phosphoprotein</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">TREM2 Agonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TREM2 Antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Small Molecule SYK Activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">117 edges</a></td>
</tr>
</table>

Tyrobp Dap12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

TYROBP (DAP12) is a transmembrane signaling adaptor protein that associates with [TREM2](/proteins/trem2-protein) to regulate microglial function in the brain. It is a critical component of the innate immune signaling pathway in myeloid cells, particularly [microglia](/cell-types/microglia-neuroinflammation) in the central nervous system. [@rudy2001]

Overview

Structure

DAP12 is a type I transmembrane protein with:

Short extracellular domain (10 amino acids) - minimal extracellular portion
Single transmembrane helix - contains charged residue for receptor association
Cytoplasmic ITAM (Immunoreceptor Tyrosine-based Activation Motif) - YxxL/I motif that becomes phosphorylated

The ITAM motif contains the sequence YxxL/I that, when phosphorylated, creates a docking site for SYK family kinases.

Molecular Mechanisms

Signal Transduction Cascade

DAP12 transduces signals when associated with activating receptors:

Receptor-ligand interaction - [TREM2](/genes/trem2) binds to ligands ([Aβ](/proteins/amyloid-beta), lipids, apolipoproteins)

ITAM phosphorylation - Src family kinases (Fyn, Lyn) phosphorylate ITAM tyrosines

SYK recruitment - Phosphorylated ITAM recruits SYK/ZAP70 family kinases

Downstream activation - SYK activates multiple signaling pathways:

PI3K/Akt pathway → cell survival, metabolism
MAPK/ERK pathway → cell proliferation, differentiation
[NF-κB](/entities/nf-kb) pathway → inflammatory gene expression
PLC-γ pathway → calcium signaling, cytoskeletal reorganization

TREM2-DAP12 Complex

TREM2 and DAP12 form a functional signaling complex
DAP12 is constitutively associated with TREM2 in the membrane
Ligand binding to TREM2 triggers rapid ITAM phosphorylation

Normal Function

DAP12 transduces signals when associated with activating receptors:

TREM2 (Triggering Receptor Expressed on Myeloid Cells 2)
Other triggering receptors on myeloid cells including CLEC5A, CLECSF12

Signaling through DAP12 regulates:

Microglial survival and proliferation - Akt-dependent pro-survival signaling
Phagocytosis - Critical for [Aβ](/proteins/amyloid-beta) and debris clearance
Cytokine production - Controls inflammatory response magnitude
Process extension and migration - Cytoskeletal dynamics for surveillance

This signaling maintains brain homeostasis and enables microglia to respond to pathology.

Role in Disease

Alzheimer's Disease

TREM2-DAP12 signaling is critical for microglial Aβ clearance
Risk variants (R47H, R62H) impair signaling and microglial function
DAP12 expression significantly elevated near amyloid plaques
Variants associated with reduced clusterin levels and altered lipid metabolism
Therapeutic strategies aim to enhance TREM2-DAP12 signaling

Nasu-Hakola Disease (PLOSL)

Loss-of-function mutations in TYROBP cause autosomal recessive disease
Characterized by early-onset dementia and bone cysts
Demonstrates critical role in brain function and bone metabolism

Parkinson's Disease

DAP12-mediated signaling in microglial activation
Involved in [α-synuclein](/proteins/alpha-synuclein) clearance mechanisms
May contribute to neuroinflammation in PD pathogenesis

Other Associations

Amyotrophic lateral sclerosis (ALS)
Multiple sclerosis
Traumatic brain injury response

Biomarkers

Therapeutic Targeting

Therapeutic Rationale

In Alzheimer's disease, enhancing TREM2-DAP12 signaling may:

Restore microglial Aβ clearance
Reduce neuroinflammation
Promote protective microglial responses (DAM phenotype)

Animal Models

Tyrobp knockout mice: Exhibit impaired microglial function, increased amyloid deposition
Trem2 knockout mice: Phenocopy many aspects of TREM2 deficiency
Trem2/R47H knock-in mice: Model human risk variant, show intermediate phenotype

Key Publications

Guerreiro RJ, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117-27. PMID: 23150934(https://pubmed.ncbi.nlm.nih.gov/23150934/)

Paloneva J, et al. TYROBP mutations in Nasu-Hakola disease. Nat Genet. 2002;31(3):321-3. PMID: 12032567(https://pubmed.ncbi.nlm.nih.gov/12032567/)

Peng Q, et al. TYROBP deficiency in microglia accelerates Alzheimer's disease pathology. Nat Neurosci. 2020;23(9):1112-1121. PMID: 32747753(https://pubmed.ncbi.nlm.nih.gov/32747753/)

Konishi H, Kiyama H. Microglial TREM2/DAP12 signaling: A promising therapeutic target for Alzheimer's disease. Front Aging Neurosci. 2020;12:56. PMID: 32210765(https://pubmed.ncbi.nlm.nih.gov/32210765/)

Lanier LL, Bakker AB. The ITAM-bearing adapters in innate immunity. Nat Rev Immunol. 2002;2(1):31-40. PMID: 11905831(https://pubmed.ncbi.nlm.nih.gov/11905831/)

Background

The study of Tyrobp Dap12 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: Q9Y258](https://www.uniprot.org/uniprot/Q9Y258)
[NCBI Gene: TYROBP](https://www.ncbi.nlm.nih.gov/gene/7305)

Last updated: 2026-03-04

References

[Jan LY, Jan YN, Potassium channels and their regulatory mechanisms (1994)](https://pubmed.ncbi.nlm.nih.gov/7513245/)

[Rudy B, McBain CJ, Kv1 channels: knobs, holes, and the basics of electrical excitability (2001)](https://pubmed.ncbi.nlm.nih.gov/11719293/)

[Robbins J, Tempel BL, Kv1.1 and Kv1.2: equivalent charybdotoxin-sensitive channels? Proc Natl Acad Sci (1997)](https://pubmed.ncbi.nlm.nih.gov/9342319/)

[Herson PS, Brown R, Hensley J, et al, Kv1.1 channels in neuronal excitability (2003)](https://pubmed.ncbi.nlm.nih.gov/15065872/)

[Southan AP, Robertson B, Electrophysiological characterization of voltage-gated K+ currents in cerebellar granule cells (1998)](https://pubmed.ncbi.nlm.nih.gov/9566978/)

📖 View canonical wiki page →

Related Entities

TYROBPPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-tyrobp-protein
kg_node_id	TYROBPPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d6bffc84e2af
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-tyrobp-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

19

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TYROBP/DAP12 Protein

TYROBP/DAP12 Protein

Introduction

TYROBP/DAP12 Protein

Introduction

Overview

Structure

Molecular Mechanisms

Signal Transduction Cascade

TREM2-DAP12 Complex

Normal Function

Role in Disease

Alzheimer's Disease

Nasu-Hakola Disease (PLOSL)

Parkinson's Disease

Other Associations

Biomarkers

Therapeutic Targeting

Therapeutic Rationale

Animal Models

Key Publications

See Also

Background

External Links

References

💬 Discussion